Pacific Horizon Ventures was formed in 1993 and is focused on the life sciences. We invest in early-stage in life science technologies that address significant healthcare problems in poorly served markets. These are opportunities that have the potential to change the societal healthcare equation. Most often, this means the development of products based on biotechnology or pharmaceutical chemistry but we are receptive to opportunities in medical devices, computational biology and genomics. We are active investors who take a hands-on role in the general management of portfolio companies during the early stages of development. We have a successful track record identifying and developing promising early-stage opportunities that have particular promise. © Pacific Horizon Ventures.